Search Results 211-220 of 16130 for anti-TNF drugs

1. Drug-eluting stents: Do they increase heart attack risk? - Mayo Clinic

   It also might be possible to stop taking anti-clotting medicines six months after stent placement, but only with the approval of a care team. After getting a ...

2. Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD) - Mayo Clinic

   Demonstrated intolerance or inadequate response to one or more anti-tumor necrosis factor (TNF) therapies. Exclusion Criteria: Current diagnosis of ...

3. A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower130) - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... [anti-TNF] agents) within 2 weeks prior to randomization. Patients who have ...

4. Diphenoxylate and atropine (oral route) - Mayo Clinic

   Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for ...

5. Efavirenz, emtricitabine, and tenofovir (oral route) - Mayo Clinic

   Efavirenz, emtricitabine, and tenofovir combination is used alone or with other anti-HIV medicines to treat human immunodeficiency virus (HIV) infection.

6. Valley fever - Diagnosis & treatment - Mayo Clinic

   ... medication, such as fluconazole. Antifungal medications are also used for people with chronic or disseminated disease. The antifungal drugs fluconazole ...

7. Nystatin and triamcinolone (topical route) - Mayo Clinic

   Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for ...

8. Drugs and Supplements that Start with T - Mayo Clinic

   Therasoft Anti-Acne. Also known as. Salicylic acid (topical route). Therasoft Anti-Itch & Dermatitis. Also known as. Hydrocortisone (topical application route).

9. Targeted Drug Therapy Clinical Trials - Mayo Clinic Research

   The primary purpose of this study is to assess the anti-tumor activity of LGX818/MEK162 in combination with targeted agents after progression on LGX818/MEK162 ...

10. Publications - Jana G. Al Hashash, M.D., M.S. - Mayo Clinic

    The Clinical Utility of Precision-Guided Dosing for Adalimumab Therapy Optimization in Inflammatory Bowel Disease: A Clinical Experience Program.